KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Progyny (PGNY) Accumulated Expenses (2018 - 2025)

Progyny (PGNY) has disclosed Accumulated Expenses for 8 consecutive years, with $78.3 million as the latest value for Q4 2025.

  • On a quarterly basis, Accumulated Expenses changed N/A to $78.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was $78.3 million, a N/A change, with the full-year FY2025 number at $78.3 million, changed N/A from a year prior.
  • Accumulated Expenses was $78.3 million for Q4 2025 at Progyny, down from $87.4 million in the prior quarter.
  • In the past five years, Accumulated Expenses ranged from a high of $91.4 million in Q1 2025 to a low of $37.4 million in Q4 2021.
  • A 5-year average of $62.4 million and a median of $61.2 million in 2023 define the central range for Accumulated Expenses.
  • Peak YoY movement for Accumulated Expenses: skyrocketed 122.71% in 2021, then increased 0.8% in 2022.
  • Progyny's Accumulated Expenses stood at $37.4 million in 2021, then skyrocketed by 34.27% to $50.2 million in 2022, then increased by 20.45% to $60.5 million in 2023, then grew by 28.89% to $78.0 million in 2024, then grew by 0.4% to $78.3 million in 2025.
  • Per Business Quant, the three most recent readings for PGNY's Accumulated Expenses are $78.3 million (Q4 2025), $87.4 million (Q3 2025), and $79.9 million (Q2 2025).